Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception

NCT: NCT03067272 · COMPLETED

NCT IDNCT03067272
StatusCOMPLETED
Start Date2017-03-15
Completion2023-03-14
SponsorFemasys Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Prospective, multi-center, pilot study evaluating the safety of the FemBloc® Permanent Contraceptive System for female sterilization in preventing pregnancy.

Frequently Asked Questions

What is Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception?

Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception is a clinical trial registered under NCT03067272. Current status: COMPLETED.

What is the status of NCT03067272?

The current status of NCT03067272 (Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception) is: COMPLETED.

When did Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception start?

Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception started on 2017-03-15.

Related Devices

K231730FemaSeed Intratubal InseminationFemasys, Inc. K241693FemChec Controlled Saline-Air Device (FCD-250)Femasys, Inc. K242002FemVue MINI Saline-Air DeviceFemasys, Inc. K253403FemVue® Controlled Saline-Air Device (FSA-300)Femasys, Inc. PMA P020014Transcervical contraceptive tubal occlusion deviceBayer Pharma AG

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑